AFFiRiS develops and manufactures peptide-based vaccines for therapeutic treatment of chronic diseases. AFFiRiS was founded in 2004. AFFiRiS's headquarters is located in Vienna, Vienna, AT 1030.
AFFiRiS's CEO, Oliver Siegel, currently has an approval...
AFFiRiS's CEO, Oliver Siegel, currently has an approval
rating of 70%. AFFiRiS's primary competitors are
There are no competitors identified for AFFiRiS
There have been no acquisitions found related to AFFiRiS
Recent investment data cannot be found related to AFFiRiS